Raymond Woosley
Gründer bei Critical Path Institute
Vermögen: - $ am 30.04.2024
Profil
Raymond L.
Woosley is the founder of Critical Path Institute, which was founded in 2004.
He served as the Chairman, President & Chief Executive Officer from 2005 to 2011.
Dr. Woosley currently holds several positions.
Since 2012, he has been the Director of the Arizona Center for Education & Research on Therapeutics.
He is also a Director at Crediblemeds Worldwide, Inc. since 2012.
In addition, he has been a Professor at the University of Arizona College of Medicine since 2015.
Lastly, he has been a Professor at the Arizona Health Sciences Center since 2001.
Dr. Woosley has held former positions as well.
From 2013 to 2024, he was an Independent Director at ARCA biopharma, Inc. From 1988 to 2001, he served as the Director-Cardiovascular Sciences Institute at Georgetown University School of Medicine.
He was also the Director at Ucl Institute of Cardiovascular Science from 1994 to 2000.
Furthermore, he was a Member at Vanderbilt University from 1976 to 1988.
Dr. Woosley obtained his doctorate degree from the University of Louisville and the University of Miami.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARCA BIOPHARMA, INC.
-.--% | 30.01.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Raymond Woosley
| Unternehmen | Position | Beginn |
|---|---|---|
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Gründer | 01.11.2004 |
| Arizona Center for Education & Research on Therapeutics | Direktor/Vorstandsmitglied | 01.01.2012 |
| Arizona Health Sciences Center | Corporate Officer/Principal | 01.01.2001 |
| Crediblemeds Worldwide, Inc. | Direktor/Vorstandsmitglied | 01.01.2012 |
| University of Arizona College of Medicine | Corporate Officer/Principal | 01.01.2015 |
Ehemalige bekannte Positionen von Raymond Woosley
| Unternehmen | Position | Ende |
|---|---|---|
| ARCA BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 02.02.2024 |
| Georgetown University School of Medicine | Corporate Officer/Principal | 01.01.2001 |
| Ucl Institute of Cardiovascular Science | Direktor/Vorstandsmitglied | 01.01.2000 |
| Vanderbilt University | Corporate Officer/Principal | 01.01.1988 |
Ausbildung von Raymond Woosley
| University of Louisville | Doctorate Degree |
| University of Miami | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARCA BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Commercial Services |
| Arizona Health Sciences Center | |
| Crediblemeds Worldwide, Inc. | |
| Ucl Institute of Cardiovascular Science | |
| Arizona Center for Education & Research on Therapeutics |
